MA
NUVL

Montag & Associates’s Nuvalent NUVL Stock Holding History

Montag & Associates’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$793 Buy
+8
New +$815 ﹤0.01% 910

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Montag & Associates's NUVL Position: Q1 2026 in Review

Montag & Associates opened a new position in Nuvalent (NUVL) in Q1 2026: 8 shares worth $793. The stake represents ﹤0.01% of the portfolio and ranks #910 among its holdings.

263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Montag & Associates held 8 shares of Nuvalent worth $793 as of Q1 2026.
  • Nuvalent was a new Montag & Associates position in Q1 2026.
  • Nuvalent made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #910 holding.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.